ProQR Therapeutics N.V. (PRQR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 87.07M | 100.08M | 111.33M | 124.28M | 149.16M | 153.84M | 92.41M | 101.77M | 115.73M | 133.65M | 132.01M | 131.15M |
| Cash & Short-Term Investments | 81.17M | 92.37M | 106.88M | 119.77M | 143.03M | 149.41M | 89.4M | 96.15M | 110.93M | 131.37M | 127.63M | 128.56M |
| Cash Only | 81.17M | 92.37M | 106.88M | 119.77M | 143.03M | 149.41M | 89.4M | 78.97M | 92.57M | 131.37M | 127.63M | 128.56M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.18M | 18.36M | 0 | 0 | 0 |
| Accounts Receivable | 2.72M | 5.08M | 0 | 0 | 2.98M | 0 | 0 | 0 | 3.4M | 1.4M | 3.35M | 400K |
| Days Sales Outstanding | 169.92 | 100.71 | - | - | 59.31 | - | - | - | 49.13 | 66.56 | 125.94 | 31.37 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -521 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 576K | 2.43M | 0 | 2.03M | 1.3M | 4.55M | 0 | 0 | 0 | 2.19M |
| Total Non-Current Assets | 12.06M | 12.62M | 13.02M | 13.26M | 14.7M | 14.11M | 14.44M | 16.29M | 18.06M | 18.67M | 18.37M | 16.84M |
| Property, Plant & Equipment | 12.06M | 12.62M | 13.02M | 13.26M | 14.7M | 14.11M | 14.44M | 16.29M | 18.06M | 18.67M | 18.37M | 16.22M |
| Fixed Asset Turnover | 0.17x | 0.36x | 0.22x | 0.27x | 0.31x | 0.30x | 0.25x | 0.37x | 0.24x | 0.18x | 0.08x | 0.08x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 621K |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 99.14M | 112.71M | 124.35M | 137.54M | 163.85M | 167.96M | 106.85M | 118.05M | 133.79M | 152.31M | 150.38M | 147.99M |
| Asset Turnover | 0.02x | 0.04x | 0.02x | 0.03x | 0.03x | 0.03x | 0.03x | 0.05x | 0.03x | 0.02x | 0.01x | 0.01x |
| Asset Growth % | -39.5% | -32.9% | 16.38% | 16.51% | 22.48% | 10.27% | -28.95% | -20.23% | -15.33% | -11.1% | 23.53% | -17.35% |
| Total Current Liabilities | 35.09M | 32.43M | 33.14M | 33.09M | 36.42M | 38.9M | 39.64M | 37.28M | 37.17M | 37.78M | 28.21M | 22.98M |
| Accounts Payable | 189.2K | 297.87K | 305K | 1.28M | 447.2K | 16K | 31K | 33K | 357.48K | 1.7M | 123.87K | 119K |
| Days Payables Outstanding | 31.07 | 41.23 | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 4.62M | 4.44M | 4.8M | 4.73M | 4.71M | 4.58M | 4.51M | 4.44M | 4.74M | 1.78M | 4.05M | 2.92M |
| Deferred Revenue (Current) | 19.63M | 17.54M | 0 | 0 | 20.79M | 0 | 0 | 0 | 22.21M | 22.72M | 17.37M | 13.14M |
| Other Current Liabilities | 10.66M | 10.14M | 26.24M | 25.14M | 10.47M | 31.26M | 32.34M | 29.69M | 9.86M | 11.58M | 6.67M | 4.4M |
| Current Ratio | 2.48x | 3.09x | 3.36x | 3.76x | 4.10x | 3.95x | 2.33x | 2.73x | 3.11x | 3.54x | 4.68x | 5.71x |
| Quick Ratio | 2.48x | 3.09x | 3.36x | 3.76x | 4.10x | 3.95x | 2.33x | 2.73x | 3.11x | 3.54x | 4.68x | 5.71x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 26.41M | 30.93M | 34.14M | 37.47M | 42.17M | 40.5M | 42.23M | 47.92M | 59.01M | 68.81M | 73.1M | 73.51M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.74M | 3.06M | 3.58M |
| Capital Lease Obligations | 9.08M | 9.54M | 10.02M | 10.48M | 11.6M | 11.07M | 11.5M | 13.08M | 14.44M | 15.28M | 15.41M | 13.7M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 24.13M | 26.98M | 0 | 29.43M | 30.73M | 34.84M | 0 | 0 | 0 | 0 |
| Total Liabilities | 61.5M | 63.36M | 67.28M | 70.55M | 78.59M | 79.4M | 81.87M | 85.2M | 96.18M | 106.59M | 101.32M | 96.49M |
| Total Debt | 13.7M | 13.99M | 16.49M | 16.86M | 16.31M | 17.22M | 17.4M | 19.19M | 19.18M | 21.8M | 22.52M | 21.53M |
| Net Debt | -67.47M | -78.39M | -90.39M | -102.9M | -126.73M | -132.19M | -72M | -59.78M | -73.39M | -109.57M | -105.11M | -107.03M |
| Debt / Equity | 0.36x | 0.28x | 0.29x | 0.25x | 0.19x | 0.19x | 0.70x | 0.58x | 0.51x | 0.48x | 0.46x | 0.42x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | -1387.82x | -2811.63x | -3.68x | -700.04x | -8521.28x |
| Total Equity | 37.64M | 49.35M | 57.07M | 66.98M | 85.27M | 88.56M | 24.98M | 32.85M | 37.61M | 45.72M | 49.06M | 51.5M |
| Equity Growth % | -55.86% | -44.27% | 128.45% | 103.88% | 126.73% | 93.69% | -49.08% | -36.21% | -35.94% | -31.43% | -23.98% | -40.79% |
| Book Value per Share | 0.36 | 0.48 | 0.52 | 0.64 | 0.81 | 1.08 | 0.31 | 0.40 | 0.46 | 0.58 | 0.61 | 0.64 |
| Total Shareholders' Equity | 37.64M | 49.35M | 57.07M | 66.98M | 85.27M | 88.56M | 24.98M | 32.85M | 37.61M | 45.72M | 49.06M | 51.79M |
| Common Stock | 4.31M | 4.31M | 57.07M | 4.31M | 4.65M | 4.31M | 3.37M | 3.37M | 3.64M | 3.72M | 3.57M | 3.37M |
| Retained Earnings | -479.39M | -467.31M | 0 | -447.77M | -471.22M | -427.16M | -418.02M | -410.55M | -440.85M | -442.8M | -418.98M | -391.93M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 28.33M | 28.68M | 0 | 26.57M | 29.14M | 27.6M | 26.57M | 26.97M | 28.71M | 28.69M | 27.53M | 1M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -290K |